Miracle Mile Advisors’s ResMed RMD Stock Holding History

Miracle Mile Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$249K	Sell	1,110 -32	-3%	-$7.97K	﹤0.01%	784
2025 Q4	$275K	Sell	1,142 -8	-0.7%	-$2.05K	﹤0.01%	739
2025 Q3	$315K	Buy	1,150 +54	+5%	+$14.8K	﹤0.01%	670
2025 Q2	$283K	Buy	1,096 +173	+19%	+$41.3K	﹤0.01%	598
2025 Q1	$207K	Buy	923 +6	+0.7%	+$1.4K	﹤0.01%	605
2024 Q4	$210K	Buy	917 +77	+9%	+$18.5K	﹤0.01%	595
2024 Q3	$205K	Buy	+840	New	+$188K	﹤0.01%	493
2024 Q1	–	Sell	-1,600	Closed	-$275K	–	519
2023 Q4	$275K	Buy	+1,600	New	+$246K	0.01%	408

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Miracle Mile Advisors's RMD Position: Q1 2026 in Review

Miracle Mile Advisors reduced its ResMed (RMD) stake by 2.8% in Q1 2026, selling an estimated $7.97K and leaving 1,110 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

Miracle Mile Advisors first reported a position in RMD in Q4 2023 and has held it in 8 quarters since. The position peaked at $315K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Miracle Mile Advisors held 1,110 shares of ResMed worth $249K as of Q1 2026.
Miracle Mile Advisors sold 32 ResMed shares in Q1 2026, an estimated $7.97K.
ResMed made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q1 2026, its #784 holding.
Miracle Mile Advisors first reported a position in ResMed in Q4 2023 and has held it in 8 quarters since.
Miracle Mile Advisors's ResMed position peaked at $315K in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.